Molecular analysis of paired tumours: Time to start treating the field

Oral Oncology

Volumn 41, Issue 9, 2005, Pages 916-926

  Pateromichelakis, Stelios ^a   Farahani, Mosavar ^a   Phillips, Elaine ^a   Partridge, Max ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Clonality; Head and neck squamous cell carcinoma; Multiple tumours; Oral cancer; Second primary tumour; Synchronous tumours

Indexed keywords

PROTEIN P53;

ADULT; AGED; ALLELE; ALLELIC IMBALANCE; CHROMOSOME ARM; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE LOCUS; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; LUNG TUMOR; MALE; MOUTH LESION; MUCOSA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK; SECOND CANCER;

EID: 24644441008     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.05.002     Document Type: Article

References (47)

1. G.C. Bedi, W.H. Westra, E. Gabrielson, W. Koch, and D. Sidransky Multiple head and neck tumours: evidence for a common clonal origin Cancer Res 56 1996 2484 2487
2. P.P. Leong, B. Rezai, and W.M. Koch Distinguishing second primary tumours from lung metastases in patients with head and neck squamous cell carcinoma J Nat Cancer Inst 90 1998 927 977
3. M.J. Worsham, S.R. Wolman, T.E. Carey, R.J. Zarbo, M.S. Benninger, and D.L. Van Dyke Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumour karyotypes and fluorescence in situ hybridisation Hum Pathol 26 1995 251 261
4. A.G.M. Scholes, J.A. Woolgar, and M.A. Boyle Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 58 1998 2003 2006
5. J.A. Brennan, J.O. Boyle, and W.M. Koch Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck New Engl J Med 332 1995 712 717
6. M. Partridge, S.R. Li, and S. Pateromichelakis Detection of minimal residual cancer to investigate why all tumours recur despite seemingly adequate treatment Clin Cancer Res 6 2000 2718 2725
7. M.P. Tabor, R.H. Brakenhoff, and V.M. van Houten Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications Clin Cancer Res 7 2001 1523 1532
8. L. Mao, A.K. El-Naggar, and V. Papadimitrakopoulou Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy J Nat Cancer Inst 90 1998 1545 1551
9. M. Partridge, G. Emilion, S. Pateromichelakis, E. Phillips, and J.D. Langdon Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions Oral Oncol 33B 1997 332 337
10. J. Califano, W.H. Westra, and W. Koch Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin J Nat Cancer Inst 91 1999 599 604
11. S.J. Jang, I. Chiba, A. Hirai, W.K. Hong, and L. Mao Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 20 2001 2235 2242
12. M. Partridge, R.H. Brakenhoff, and E. Phillips Detection of rare disseminated tumour cells identifies head and neck cancer patients at risk of treatment failure Clin Cancer Res 9 2003 5287 5294
13. C.A.T. Billroth Ein Gesamtbericht uber die chirurgische kliniken in Zurich und Wein wahrend der jahre 1870-1976 Erfahrungen auf dem gebiete der prakrischen chirurgie 1879 Hirschwald Berlin p. 258
14. W. Shields, and O. Gates Multiple primary malignant tumours: a survey of the literature and a statistical study Am J Cancer 16 1932 1358 1414
15. W.K. Hong, S.M. Lippman, and L.M. Itri Prevention of second primary tumours with isotretinoin in squamous cell carcinoma of the head and neck New Engl J Med 323 1990 795 801
16. D. Gasparotto, R. Maestro, and L. Barzan Recurrences and second primary tumours in the head and neck region: differentiation by p53 mutation analysis Ann Oncol 6 1995 933 939
17. T. Hayashi, H. Sagawa, K. Kobuke, K. Fujii, H. Yokozaki, and E. Tahara Molecular-pathological analysis of a patient with three synchronous squamous cell carcinomas in the aerodigestive tract Jpn J Clin Oncol 26 1996 368 373
18. M.G.C.T. van Oijen, V.D. Leppers, F.G.J. Straat, M.G.J. Tilanus, and P.J. Slootweg The origins of multiple squamous cell carcinomas in the aerodigestive tract Cancer 88 2000 884 893
19. J.R. van der Sijp, J.P. van Meerbeeck, and A.P. Maat Determination of the molecular relationship between multiple tumors within one patient is of clinical importance J Clin Oncol 20 2002 1105 1114
20. M. Partridge, S. Pateromichelakis, E. Phillips, G.G. Emilion, and J.D. Langdon Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma Clin Cancer Res 7 2001 1860 1866
21. L. Zhang, J. Epstein, and P. Band Local tumor recurrence or emergence of a new primary lesion? A molecular analysis J Oral Pathol Med 28 1999 381 384
22. M. Partridge, S. Kiguwa, and J.D. Langdon Frequent deletion of chromosome 3p in oral squamous cell carcinoma Oral Oncol 30B 1994 248 251
23. A. Kropveld, A.D. van Mansfeld, N. Nabben, G.J. Hordijk, and P.J. Slootweg Discordance of p53 status in matched primary tumours and metastases in head and neck squamous cell carcinoma patients Oral Oncol 32B 1996 388 393
24. K.Y. Chung, T. Mukhopadhyay, and J. Kim Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract Cancer Res 53 1993 1676 1683
25. V.M. van Houten, P.J. Snijders, and M.W. van den Brekel Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas Int J Cancer 93 2001 232 235
26. B.J. Braakhuis, M.P. Tabor, C.R. Leemans, I. van der Waal, G.B. Snow, and R.H. Brakenhoff Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions Head Neck 24 2002 198 206
27. M.P. Tabor, R.H. Brakenhoff, and H.J. Ruijter-Schippers Multiple head and neck tumors frequently originate from a single preneoplastic lesion Am J Pathol 161 2002 1051 1060
28. M. Partridge, G. Emilion, S. Pateromichelakis, E. Phillips, and J.D. Langdon Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinoma Int J Cancer 83 1999 318 326
29. M. Partridge, G. Emilion, and M. Falworth Patient-specific mutation databases for oral cancer Int J Cancer 84 1999 284 292
30. M. Partridge, G. Emilion, and S. Pateromichelakis The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer Br J Cancer 79 1999 1821 1827
31. Z. Guo, U. Thunberg, J. Sallstrom, E. Wilander, and J. Ponten Clonality analysis of cervical cancer on microdissected archival materials by PCR-based X-chromosome inactivation approach Int J Oncol 12 1998 1327 1332
32. I. Panagopoulos, N. Panids, and S. Thelin The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14 Cancer Res 56 1996 4871 4875
33. R.S. Camplejohn, N. Sodha, and R. Gilchrist The value of rapid functional assays of germline p53 status in LFS and LFL families Br J Cancer 82 2000 1145 1148
34. D.R. Hodgson, M. Partridge, C.A. Foy, S. Pateromichelakis, S. Little, and N. Gibson Development of a facile fluorescent assay for detection of 80 mutations within the p53 gene Mol Med 8 2002 227 237
35. M. Partridge, S. Kiguwa, G. Emilion, S. Pateromichelakis, R. A'Hern, and J.D. Langdon New insights into p53 protein stabilisation in oral squamous cell carcinoma Oral Oncol 35B 1999 45 55
36. T. Soussi, and C. Beroud Assessing TP53 status in human tumours to evaluate clinical outcome Nat Rev Cancer 1 2001 233 240
37. A. Weston, C.F. Pan, and H.B. Ksieski p53 haplotype determination in breast cancer Cancer Epidem Biomar 6 1997 105 112
38. K.H. Shin, R.J. Tannyhill, X. Liu, and N.H. Park Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells Oncogene 12 1996 1089 1096
39. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Nat Cancer Inst 92 2000 709 720
40. L. Mao Can molecular assessment improve classification of head and neck premalignancy? Clin Cancer Res 6 2000 321 322
41. J. Califano, W.H. Westra, G. Meininger, R. Corio, W.M. Koch, and D. Sidransky Genetic progression and clonal relationship of recurrent premalignant head and neck lesions Clin Cancer Res 6 2000 347 352
42. V.M. van Houten, M.P. Tabor, and M.W. van den Brekel Mutated p53 as a molecular marker for the diagnosis of head and neck cancer J Pathol 198 2002 476 486
43. M.P. Tabor, B.J. Braakhuis, and J.E. van der Wal Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx J Pathol 199 2003 354 360
44. F. Cianfriglia, D.A. Di Gregorio, and A. Manieri Multiple primary tumours in patients with oral squamous cell carcinoma Oral Oncol 35 1999 157 163
45. S. Kaneko, and N. Yamaguchi Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Centre, Japan, 1962-1996 Jpn J Clin Oncol 29 1999 96 105
46. P.M. Harari Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma J Nat Cancer Inst 90 1998 1571
47. D.T. Curiel The development of conditionally replicative adenoviruses for cancer therapy Clin Cancer Res 6 2000 3395 3399